AC
IMGN

Armistice Capital’s Immunogen Inc IMGN Stock Holding History

Armistice Capital’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-134,698
Closed -$3.99M – 431
2023
Q4 		$3.99M Buy
+134,698
New +$2.68M 0.05% 130

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Armistice Capital's IMGN Position: Q1 2024 in Review

Armistice Capital sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 134,698 shares — an estimated $3.99M sold.

Armistice Capital first reported a position in IMGN in Q4 2023 and held it in 1 quarter. The position peaked at $3.99M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Armistice Capital reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Armistice Capital sold 134,698 Immunogen Inc shares in Q1 2024, an estimated $3.99M.
  • Armistice Capital first reported a position in Immunogen Inc in Q4 2023 and held it in 1 quarter.
  • Armistice Capital's Immunogen Inc position peaked at $3.99M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Armistice Capital's 13F filing for Q1 2024, filed 15 May 2024.